FDA Approves New Laser for Use in LASIK Procedures

The Food and Drug Administration (FDA) has recently approved a new laser for use in LASIK procedures. The Technolas Advanced Control Eyetracking (ACE) laser, produced by Bausch & Lomb, provides patients with revolutionary new technology that should dramatically improve the safety and precision of laser eye surgery procedures.

Eyetracking technology enables the laser to compensate for eye movements during the LASIK procedure. While other lasers approved by the FDA have incorporated this technology, the Technolas ACE laser is the first to be able to adjust for subtle rotations of the eye. Prior to the start of the procedure, the eyetracker locks on to the eye's unique iris pattern. When rotation of the iris pattern is detected during the procedure, the direction of laser pulses instantly gets modified to compensate for these rotations. As a result, each laser pulse during the LASIK procedure will act on its intended location on the cornea.

Approximately 2,000 LASIK procedures using this laser have been evaluated in medical studies. The results clearly show that the active, rotational eyetracking technology of the ACE laser considerably improves the safety and accuracy of LASIK outcomes. Eye rotation can result in only a partial correction of astigmatism as well as an increased likelihood of the need for an enhancement procedure. ACE technology greatly reduces these risks.

Please contact the LASIK Directory today to find an experienced laser eye surgeon in your area.